Offer - Urjas Oil for just ₹ 1
Gemizan 200 Injection is a prescription medicine that is available as a Injection. Pancreatic Cancer, Non-Small Cell Lung Cancer are some of its major therapeutic uses. Secondary and off-label uses of Gemizan 200 Injection have also been mentioned below.
The right dosage of Gemizan 200 Injection depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Gemizan 200 Injection as well, which are listed below. These side effects of Gemizan 200 Injection are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Gemizan 200 Injection's effect during pregnancy is Unknown and Severe while nursing. It is important to know if Gemizan 200 Injection has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Gemizan 200 Injection related warnings section.
Gemizan 200 Injection is not recommended if you suffer from certain medical conditions as it can have adverse effects. Heart Disease, Infections are examples of such conditions. The section on Gemizan 200 Injection contraindications lists all such conditions.
Besides this, Gemizan 200 Injection may also have severe interaction with some medicines. A complete list of these interactions is given below.
In addition to the above precautions for Gemizan 200 Injection, it is important to know that it is safe while driving, and is habit-forming.
Gemizan 200 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult(Female) |
|
| Adult |
|
| Geriatric |
|
Is the use of Gemizan 200 Injection safe for pregnant women?
The effects of Gemizan on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Gemizan 200 Injection safe during breastfeeding?
Taking Gemizan may lead to serious side effects if you are breastfeeding. Gemizan should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Gemizan 200 Injection on the Kidneys?
Gemizan rarely affects the kidneys.
What is the effect of Gemizan 200 Injection on the Liver?
The liver can be affected by Gemizan. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Gemizan only after medical advice.
What is the effect of Gemizan 200 Injection on the Heart?
Gemizan is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Gemizan 200 Injection unless your doctor advises you to do so -
Is this Gemizan 200 Injection habit forming or addictive?
Gemizan 200 Injection does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Gemizan 200 Injection will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Gemizan 200 Injection should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Gemizan 200 Injection cannot treat any kind of mental disorder.
Interaction between Food and Gemizan 200 Injection
Due to a lack of research, nothing can be said about the consequences of taking Gemizan 200 Injection together with food.
Interaction between Alcohol and Gemizan 200 Injection
Due to lack of research, there is no information about the side effects of taking Gemizan 200 Injection with alcohol.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gemzar® (Gemcitabine HCl)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 612-614
